DCVC (S-[(1E)-1,2-dichloroethenyl]-L-cysteine) is used to inhibit the release of pro-inflammatory cytokines (IL-1β, IL-8, and TNF-α) from pathogen-stimulated tissue cultures in a concentration-dependent manner; it shows inhibitory effects against cytokine release induced by lipoteichoic acid (LTA), lipopolysaccharide (LPS), and Group B Streptococcus (GBS).